Device Trial Radar · NCT03635996
Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302
Last checked: Nov 20, 2026Latest source record: Nov 5, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
169
Actual
Start
Dec 10, 2018
Primary completion
Nov 13, 2020
Study completion Nov 13, 2020
Sponsor
- Lead sponsor
- Milestone Pharmaceuticals Inc.Academic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Medpace, Inc.
- First posted
- Aug 17, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to evaluate the safety of etripamil nasal spray (NS) 70 mg when self-administered by patients with an episode of Paroxysmal Supraventricular Tachycardia in an outpatient setting (i.e., without medical supervision).
Conditions
- Paroxysmal Supraventricular Tachycardia
Interventions
Etripamil NS 70 mgDrug
All patients will receive a total of 200 micro-liters of etripamil NS 70 mg via the Aptar Pharma Nasal Spray Bidose System each time they self-administer study drug.
Aptar Pharma Nasal Spray Bidose SystemDevice
Patients will self-administer the study drug using the Aptar Pharma Nasal Spray Bidose System. The devices will be prefilled and packaged into child-resistant boxes.Instructions for its use will be provided in the study drug box.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to Conversion of an Episode of PSVT to Sinus Rhythm (SR) After Study Drug Administration.Time frame: 18 months
Locations
34 sites in 2 countries. Site status is shown where the registry gives one.
Arizona Arrhythmia Research Center
Phoenix, Arizona
Arkansas Cardiology
Little Rock, Arkansas
Los Alamitos Cardiovascular
Los Alamitos, California
31 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.